Skip to main content
. 2018 Jul 30;8(16):4295–4304. doi: 10.7150/thno.26370

Figure 1.

Figure 1

Scan selection per tracer according to predefined eligibility criteria. a, Optimal imaging dose of unlabeled lumretuzumab was considered 100 mg, scans with 10 and 50 mg were excluded. b, The scans of patients with a history of a hemihepatectomy (n=1) and recurrent pleural effusion needing continuous drainage (n=1) were excluded.